What is ARQT's dilution risk score?

ARQT has a latest available DilutionScore record of 65/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ARQT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ARQT?

DilutionWatch tracks 25 SEC filing types for ARQT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ARQT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ARQT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ARQT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ARQT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ARQT Dilution Risk Score: 65/100 (HIGH)

Score Breakdown

📋 Offering Ability

32

💰 Cash Runway

95

📊 Float Risk

25

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 30%

💰 Capital Raise model 55%

• Critical: only 2.9 months cash remaining

📉 Score Deterioration model 10%

• Score in HIGH risk zone (65/100)

🔔 Track ARQT — Get forecast alerts →

Market Data

Market Cap$2.68B

Shares Outstanding125.69M

Float92.59M

Cash$34.12M

Debt$108.90M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 18.6% shares (2026Q1 vs prior)

272 institutional holders · 156.41M shares

#1 MORGAN STANLEY 12.84M shares

#2 SUVRETTA CAPITAL MANAGEMENT, LLC 12.33M shares

#3 Frazier Life Sciences Management, L.P. 9.87M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.69M

Days to Cover10.7

% of Float13.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31

4 INSIDER TRANSACTION 2026-04-03

4 INSIDER TRANSACTION 2026-03-04

4 INSIDER TRANSACTION 2026-03-03

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ARQT Dilution Snapshot

Arcutis Biotherapeutics, Inc. (ARQT) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for ARQT: 4 on 2026-04-03; 4 on 2026-03-04; 4 on 2026-03-04.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.